CrushSCI.com
138.6平均天数
131.5中位天数
26最短天数
282最长天数
1412025发文量

Paper Review Records

全部论文审稿周期

30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

229 天

Blocking aryl hydrocarbon receptor remodels myeloid–T cell crosstalk and enhances anti-PD-1 response in the tumor microenvironment

作者
Dong Kwon Kim; Sujeong Baek; Youngtaek Kim; Seung Min Yang; So Young Park; Su Jin Choi; Ju Hyeon Lee; Sang Hoon Lee; Jongho Cho; Daewon Cha; Dajeong Kim; Sunghwa Kim; Jae Hwan Kim; Byoung Chul Cho展开收起
作者单位
1. Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea; 2. Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea; 3. Yonsei New Il Han Institute for Integrative Lung Cancer Research, Yonsei University College of Medicine, Seoul, Korea; 4. Dong-A ST Research Institute, Yongin-si, Korea; 5. Division of Medical Oncology, Department of Internal Medicine, Severance Hospital, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea展开收起
PDF源文件 DOI 网页
40 天

Oncogenic RAS as an adaptive signaling ecosystem: context-dependent vulnerabilities and resistance-informed therapeutic design

作者
Amir Abbas Hamidi; Omeed Moaven; Reihaneh Alsadat Mahmoudian; Mohammad Reza Abbaszadegan展开收起
作者单位
1. Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; 2. Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; 3. Division of Surgical Oncology, Department of Surgery, LSU Health New Orleans School of Medicine, New Orleans, USA; 4. LSU LCMC Health Cancer Center, New Orleans, USA; 5. Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran展开收起
PDF源文件 DOI 网页
92 天

Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation

作者
Peng Huang; WenLin Wu; Yu Min; Yi Zhang; YunFeng Tao; Zheran Liu; Zhigong Wei; Xingchen Peng展开收起
作者单位
1. Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, P.R. China; 2. Nuclear Physics and Medical Research Key Laboratory of Sichuan Province, Sichuan University, Chengdu, P.R. China展开收起
PDF源文件 DOI 网页
186 天

Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma

作者
Mario Udinotti; Niclas Ramm; Thamer Abed Alhaleem Amin Hamdan; Muhammad Sameer Ali Khan; Udo Siebolts; Marcus Bauer; Kerstin Lorenz; Christine Dierks; Claudia Wickenhauser; Barbara Seliger展开收起
作者单位
1. Institute of Pathology, Section Immunopathology, Martin Luther University Halle-Wittenberg, Halle, Germany; 2. Institute of Tumor Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany; 3. Institute of Pathology, University Hospital, Cologne, Germany; 4. Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Halle, Germany; 5. Department of Hematology/Oncology and Stem Cell Transplantation, KIM IV, Martin-Luther University Halle-Wittenberg, Halle, Germany; 6. Department of Hematology and Oncology, Freiburg University Medical Center, Albert-Ludwigs-University of Freiburg, Breisgau, Germany; 7. Institute of Translational Immunology, Center for Translational Medicine, Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Brandenburg, Germany; 8. Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany展开收起
PDF源文件 DOI 网页
186 天

Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesis

作者
Yuqian Zhu; Jingwei Yao; Yuelong Jiang; Qian Lai; Qinwei Chen; Jingxing Zhang; Manman Deng; Zhijuan Lin; Yiming Luo; Zhifeng Li; Long Liu; Zhong Zheng; Jie Zha; Bing Xu展开收起
作者单位
1. Department of Hematology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; 2. Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China; 3. Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China展开收起
PDF源文件 DOI 网页
199 天

Multimodal AI and single-cell transcriptomics integrate to construct a histopathological prognostic model for bladder cancer, revealing the RTN3-glycolysis axis in chemoresistance

作者
Shunli Yu; Yingjian Wang; Dapeng Feng; Xinglai Dai; Yongbo Luo; Jianing Wang; Zihe Wang; Fuxiang Chen; Haoran Wang; Fengyan Tian; Xuejia Zhai; Chaohui Gu展开收起
作者单位
1. Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 3. Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 4. Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。